AMONDYS 45
Active substance: casimersen
INJECTION · CASIMERSEN 50 mg/mL
United StatesActive
Marketing holder: Sarepta Therapeutics, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CASIMERSEN · 50 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1209b-6a1e-7c28-b70c-7e70b1d18872;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 60923-227
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 60923-227 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 60923-227 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 60923-227 · Verified 2026-10-09 · open in source